Serum Ferritin and Hepicidin Concentration in Chronic Periodontitis Patients With T2DM
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03964428
Recruitment Status :
First Posted : May 28, 2019
Last Update Posted : June 11, 2019
Information provided by (Responsible Party):
Nayroz Abdel Fattah Mohamed Tarrad, Fayoum University
serum level of ferritin and hepicidin were evaluated in periodontitis patient with and without type 2 diabetes before and after non surgical periodontal treatment to clarify their in periodontal disease
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
30 Years to 50 Years (Adult)
Sexes Eligible for Study:
participants were collected from the Outpatient Clinic, Department of Oral Medicine, Periodontology and Diagnosis, and the restorative clinic for the control subjects, Faculty of Oral and Dental Medicine, fayoum University
patients with more than 30% of the sites had clinical attachment level (CAL) 3-4mm with T2DM
systemically healthy patients with more than 30% of the sites had clinical attachment level (CAL) 3-4mm
healthy subjects had clinically healthy gingiva with ≤ 3mm pocket probing depth (PPD), nearly zero plaque index (PI), gingival index (GI), zero CAL.
(I) Pregnancy or lactation, (II) History of receiving professional periodontal treatment during the past 6 months; (III) Treatment with any type of medications and/ or antibiotics during the past 3 months and (IV) Current or former smokers.